Amylyx Pharmaceuticals Reports Quarterly Results
Amylyx Pharmaceuticals reported results for the quarter ended September 30; the available report does not specify the figures.
Related stories
Tronox Reports Third-Quarter Revenue of $827 Million and EPS Loss of $0.34
Third-quarter net sales rose 18% year over year, while Tronox’s attributable net loss narrowed. Higher sales volumes and average selling prices for TiO₂ and zircon lifted sales and
M impact | EQUITY | Nov 05, 2026, 03:21 PM UTC
Cronos Group Shares Rise 9% After Q3 Results Top Estimates
Cronos Group shares rose 9% in Thursday trading after its Q3 results topped estimates.
M impact | EQUITY | Nov 05, 2026, 03:21 PM UTC
Washington Trust Reports Third-Quarter 2026 Revenue of $64.96M, EPS of $1.01
Revenue and earnings increased year over year, supported by higher net interest and noninterest income and a lower provision for credit losses, which more than offset higher expens
M impact | EQUITY | Nov 05, 2026, 03:21 PM UTC
Goodyear Reports Third-Quarter Revenue of $4.54B, EPS Loss of $0.82
Third-quarter sales fell 2.3% year over year, while Goodyear’s net loss narrowed sharply. Lower tire volume and divestitures weighed on sales and segment operating income; earnings
M impact | EQUITY | Nov 05, 2026, 03:21 PM UTC
Apyx Medical Reports Quarterly Results Through September 30
Apyx Medical reported results for the quarter ended September 30; the supplied report provides no financial figures.
M impact | EQUITY | Nov 05, 2026, 03:21 PM UTC
GPGI Shares Fall More Than 3% After Lower Q3 Adjusted Earnings
GPGI shares retreated more than 3% after the company reported lower Q3 adjusted earnings, while revenue increased.
M impact | EQUITY | Nov 05, 2026, 03:20 PM UTC